"TODAY, 90 years later, we are market leaders with continuous international growth. We have 5 manufacturing plants, over 900 employees, and 7 distribution centers in various cities across Paraguay. Our daily mission is to provide you with the highest quality in every medicine.".
THANK YOU FOR CHOOSING US to take care of your entire family.
Don Vicente Scavone (Italian immigrant) bought the 'Farmacia Alemana' and founded Vicente Scavone & Cia. (Laboratorios Lasca)..
In 1957, the first pharmaceutical manufacturing plant was inaugurated. A year later, the first antibiotic in Paraguay was produced there.
The construction of the facilities for the country's most important pharmaceutical company has begun.
We inaugurated the first sterile area in Paraguay, designed and implemented by Italian technicians.
Three new segregated manufacturing units for beta-lactams, antibiotics, and hormonal products have been established.
We inaugurated the first biotechnology product fractionation plant in Paraguay.
2023: Establishment of the CIDEC (Research and Development Center), which includes a development and biotechnology laboratory, a physical-chemical and quality control laboratory, and a microbiology laboratory.
In 2023, we obtained GMP INVIMA certification for our biologicals plant, which certifies compliance with international standards.
Don Vicente Scavone was born in Tito, Potenza province, Italy.
He arrived in Paraguay at the age of 10 to work with his uncles in the pharmaceutical sector.
With a vision to manufacture medicines in Paraguay.
Inaugurated the "Farmacia Alemana" and founded "Vicente Scavone & Cia".
In the center of Asunción, the first **Lasca** medicine plant was inaugurated, equipped with the most modern machinery of the time.
The first antibiotic produced in Paraguay, "Lascamicetina", was manufactured here.
The most important pharmaceutical industrial plant in the country was inaugurated in San Lorenzo.
Italian technicians set up the first sterile area in the country.
The first lyophilized antibiotics produced entirely in Paraguay were developed, marking a new milestone for the Paraguayan pharmaceutical industry.
The first physical-chemical and microbiological quality control laboratory in Paraguay was established.
Plants for beta-lactams, antibiotics, and hormonal products were inaugurated.
The first biotechnology product plant in Paraguay was inaugurated, producing medicines according to WHO standards for export to Latin America, the Middle East, Southeast Asia, Eastern Europe, and Africa.
The first laboratory to issue bonds on the stock exchange was established. During the pandemic, medicines that could not be imported at the time, such as atracurium, midazolam, enoxaparin, and ivermectin, were manufactured, saving many lives.
The Centro de Investigación, Desarrollo y Control de Calidad (CIDEC) and a new Solid Oral Medicines Plant were established. The INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos – Colombia) certification was obtained, enabling the export of enoxaparin and erythropoietin.
